Kidney function and long-term medication adherence after myocardial infarction in the elderly

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 4, 2011, Pages 864-869

  Chang, Tara I ^a   Desai, Manisha ^b   Solomon, Daniel H ^c,d   Winkelmayer, Wolfgang C ^a,d  

^a Divisions of Nephrology   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Rheumatology   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MYOCARDIAL INFARCTION;

EID: 79955550907     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07290810     Document Type: Article

References (24)

1. World Health Organization: Adherence to long-term therapies: Evidence for action. Available at: http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed August 3, 2010
2. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients. JAMA 288: 455-461, 2002
3. Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS: Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: A retrospective, cohort study. Drugs Aging 25: 885-892, 2008
4. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M: Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ 336: 1114-1117, 2008
5. Cherry SB, Benner JS, Hussein MA, Tang SS, Nichol MB: The clinical and economic burden of nonadherence with antihy-pertensive and lipid-lowering therapy in hypertensive patients. Value Health 12: 489-497, 2009
6. Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC: Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens 23: 155-160, 2010
7. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ: Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the premier registry. Circulation 113: 2803-2909, 2006
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
9. Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Sh-lipak MG: Kidney dysfunction and fatal cardiovascular dis-ease-An association independent of atherosclerotic events: Results from the health, aging, and body composition (Health ABC) study. Am Heart J 155: 62-68, 2008
10. Fried LF, Lee JS, Shlipak M, Chertow GM, Green C, Ding J, Harris T, Newman AB: Chronic kidney disease and functional limitation in older people: Health, aging and body composition study. J Am Geriatr Soc 54: 750-756, 2006
11. Tsai C-F, Wang S-J, Fuh J-L: Moderate chronic kidney disease is associated with reduced cognitive performance in midlife women. Kidney Int 78: 605-610, 2010
12. Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ: Prevalence of major depressive episode in CKD. Am J Kidney Dis 54: 424-432, 2009
13. Winkelmayer WC, Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J: Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol 1: 796-801, 2006
14. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH: Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: Estimating positive predictive value on the basis of review of hospital records. Am Heart J 148: 99-104, 2004
15. Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH: Identification of individuals with CKD from Medicare claims data: A validation study. Am J Kidney Dis 46: 225-232, 2005
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 130: 461-470, 1999
17. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the united states. JAMA 298: 2038-2047, 2007
18. Sikka R, Xia F, Aubert RE: Estimating medication persistency using administrative claims data. Am J Manag Care 11: 449-457, 2005
19. Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Saf-ford MM: Low medication adherence and hypertension control among adults with CKD: Data from the regards (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis 56: 447-457, 2010
20. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 293: 1737-1745, 2005
21. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J: Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17: 504-511, 2002
22. Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, Wolfe R, Port F, Burrows-Hudson S, Saran R: Patterns of medication use in the RRI-CKD study: Focus on medications with cardiovascular effects. Nephrol Dial Transplant 20: 1110-1115, 2005
23. Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB: Medication adherence behavior and priorities among older adults with CKD: A semistructured interview study. Am J Kidney Dis 56: 439-446, 2010
24. Morris AB, Li J, Kroenke K, Bruner-England TE,Young JM,Murray MD:Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharma-cotherapy 26: 483-492, 2006